Tao Zhu MD; AACR 2026: Anti-Claudin 6 Antibody Drug Conjugate Benefits Patients with Advanced Platinum-Resistant Ovarian Cancer with Low Toxicity episode artwork

EPISODE · Apr 28, 2026 · 4 MIN

Tao Zhu MD; AACR 2026: Anti-Claudin 6 Antibody Drug Conjugate Benefits Patients with Advanced Platinum-Resistant Ovarian Cancer with Low Toxicity

from Audio Journal of Oncology Podcast

Refractory Ovarian Cancer Yields to Claudin 6 Targeted Antibody Drug Conjugate

Episode metadata supplied by the publisher feed · Published Apr 28, 2026

Embed this episode

Ready to play

Tao Zhu MD; AACR 2026: Anti-Claudin 6 Antibody Drug Conjugate Benefits Patients with Advanced Platinum-Resistant Ovarian Cancer with Low Toxicity

0:00 4:50

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Audio Journal of Oncology Podcast?

This episode is 4 minutes long.

When was this Audio Journal of Oncology Podcast episode published?

This episode was published on April 28, 2026.

Can I download this Audio Journal of Oncology Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!